Cargando…
Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261427/ https://www.ncbi.nlm.nih.gov/pubmed/34295766 http://dx.doi.org/10.21037/tau-20-1321 |
_version_ | 1783719010467053568 |
---|---|
author | Roobol, Monique J. |
author_facet | Roobol, Monique J. |
author_sort | Roobol, Monique J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8261427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-82614272021-07-21 Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? Roobol, Monique J. Transl Androl Urol Editorial Commentary on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney) AME Publishing Company 2021-06 /pmc/articles/PMC8261427/ /pubmed/34295766 http://dx.doi.org/10.21037/tau-20-1321 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Editorial Commentary on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney) Roobol, Monique J. Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
title | Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
title_full | Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
title_fullStr | Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
title_full_unstemmed | Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
title_short | Active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
title_sort | active surveillance for prostate cancer—will the discoveries of the last 5 years change the future? |
topic | Editorial Commentary on Expectant Management in Genitourinary Malignancies (Prostate, Bladder, Kidney) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261427/ https://www.ncbi.nlm.nih.gov/pubmed/34295766 http://dx.doi.org/10.21037/tau-20-1321 |
work_keys_str_mv | AT roobolmoniquej activesurveillanceforprostatecancerwillthediscoveriesofthelast5yearschangethefuture |